Effectiveness of lurasidone in adolescents with schizophrenia: interim analysis of a 24-month, open-label extension study

被引：1
|
作者：
Tocco, M. [1 ]
Arango, C. [2 ]
Correll, C. U. [3 ]
Goldman, R. [4 ]
Cucchiaro, J. [5 ]
Deng, L. [6 ]
Loebel, A. [7 ]
机构：
[1] Sunov Pharmaceut Inc, Marlborough, MA USA
[2] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Serv Psiquiatria Nino & Adolescente, CIBERSAM,IiSGM,Fac Med, Madrid, Spain
[3] Hofstra North Shore LIJ Sch Med, Dept Psychiat & Mol Med, Hempstead, NY USA
[4] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Marlborough, MA USA
[5] Sunov Pharmaceut Inc, Clin Dev, Ft Lee, NJ USA
[6] Sunov Pharmaceut Inc, Biostat, Ft Lee, NJ USA
[7] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2017年 / 27卷
关键词：
D O I：
10.1016/S0924-977X(17)31911-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.7.b.015
引用
收藏
页码：S1100 / S1101
页数：2
相关论文
共 50 条
  • [1] Safety of lurasidone in adolescents with schizophrenia: interim analysis of a 24-month, open-label extension study
    Correll, C. U.
    Arango, C.
    Tocco, M.
    Goldman, R.
    Cucchiaro, J.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1099 - S1099
  • [2] SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 24-MONTH, OPEN-LABEL EXTENSION STUDY
    Tocco, M.
    Correll, C.
    Goldman, R.
    Cucchiaro, J.
    Deng, L.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 : 154 - 155
  • [3] SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 24-MONTH, OPEN-LABEL EXTENSION STUDY
    Tocco, M.
    Correll, C.
    Goldman, R.
    Cucchiaro, J.
    Deng, L.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 : 136 - 136
  • [4] EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 24-MONTH, OPEN-LABEL EXTENSION STUDY
    Goldman, Robert
    Tocco, Michael
    Pikalov, Andrei
    Cucchiaro, Josephine
    Deng, Ling
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S239 - S239
  • [5] EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS AT TWELVE MONTHS OF A 24-MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, Christoph
    Tocco, Michael
    Goldman, Robert
    Pikalov, Andrei A.
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S245 - S245
  • [6] EFFECT OF LURASIDONE ON COGNITION IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    Harvey, Philip D.
    Goldman, Robert
    Tocco, Michael
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S353 - S353
  • [7] EFFECTIVENESS AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: ANALYSIS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C. U.
    Tocco, M.
    Pikalov, A.
    Goldman, R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 103 - 104
  • [8] Safety and effectiveness of lurasidone in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Correll, C.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S127 - S127
  • [9] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [10] Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study
    Correll, Christoph U.
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Pikalov, Andrei
    Loebel, Antony
    CNS SPECTRUMS, 2016, 21 (05) : 393 - 402
12345